Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Marksans Pharma Limited is a pharmaceutical company, which is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 week ago•Bloomberg Quint
1 week ago•Moneycontrol
Marksans Pharma Limited has informed the Exchange regarding a press release dated April 18, 2024, titled "USFDA inspection at Company's manufacturing facility in Verna, Goa, India". | Download
Marksans Pharma Limited has informed the Exchange regarding a press release dated April 18, 2024, titled "USFDA inspection at Company's manufacturing facility in Verna, Goa, India". | Download
Final • Div/Share: ₹ 0.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant